These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9112304)

  • 1. Economic analysis of treatment with roxithromycin in comparison with erythromycin in patients with lower respiratory tract infections.
    Norinder A; Paulsen O; Hjortsberg C
    Scand J Infect Dis; 1997; 29(1):83-6. PubMed ID: 9112304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerance of roxithromycin in comparison with erythromycin stearate in patients with lower respiratory tract infections.
    Paulsen O; Christensson BA; Hebelka M; Ljungberg B; Nilsson-Ehle I; Nyman L; Svensson R; Tüll P; Varga Z
    Scand J Infect Dis; 1992; 24(2):219-25. PubMed ID: 1641600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia.
    Hatipoglu ON; Tasan Y
    Yonsei Med J; 2000 Jun; 41(3):340-4. PubMed ID: 10957888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections.
    de Campora E; Camaioni A; Leonardi M; Fardella P; Fiaoni M
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):119S-122S. PubMed ID: 1535578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roxithromycin versus cefaclor in lower respiratory tract infection: a general practice pharmacoeconomic study.
    Scott WG; Tilyard MW; Dovey SM; Cooper B; Scott HM
    Pharmacoeconomics; 1993 Aug; 4(2):122-30. PubMed ID: 10146972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study.
    Scott WG; Cooper BC; Scott HM
    Infection; 1995; 23 Suppl 1():S21-4. PubMed ID: 7782111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of roxithromycin versus cefaclor in Australia.
    Scott WG; Cooper BC; Scott HM; Tilyard MW; Dovey SM
    Pharmacoeconomics; 1995 Jan; 7(1):93-4. PubMed ID: 10155297
    [No Abstract]   [Full Text] [Related]  

  • 8. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial.
    Hopstaken RM; Nelemans P; Stobberingh EE; Muris JW; Rinkens PE; Dinant GJ
    J Fam Pract; 2002 Apr; 51(4):329-36. PubMed ID: 11978255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections.
    Laurent K
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():115-24. PubMed ID: 8818852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
    Bertrand A; Jonquet O; Sauvaget J
    Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overview.
    Gentry LO
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():145-52. PubMed ID: 3323166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acceptability, efficacy and safety of a new paediatric oral suspension of roxithromycin in respiratory tract infections.
    Moniot-Ville N; Chelly M; Consten L; Rosenbaum M
    J Int Med Res; 1998; 26(3):144-51. PubMed ID: 9718469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections.
    Tatsis G; Tsoukalas G; Boulbasakos G; Platsouka E; Anagnostopoulou M; Pirounaki M; Paniara O; Sioula E; Raptis J; Saroglou G
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():69-73. PubMed ID: 9579716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic analysis of antibiotic regimens used in the treatment pharyngitis: a prospective comparison of azithromycin versus roxithromycin.
    Carbon C; Hotton JM; Pépin LF; Wohlhuter C; Souêtre E; Hardens M; Lozet H; Riviera M
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():151-61. PubMed ID: 8818856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roxithromycin and lower respiratory tract infections.
    Scott WG; Cooper BC; Scott HM; Karalus NC; Garrett J; Lang SD
    N Z Med J; 1994 May; 107(978):208. PubMed ID: 7980759
    [No Abstract]   [Full Text] [Related]  

  • 16. Roxithromycin vs cefaclor.
    Hughes T; Scott WG; Scott HM
    Pharmacoeconomics; 1993 Nov; 4(5):396-8. PubMed ID: 10146876
    [No Abstract]   [Full Text] [Related]  

  • 17. Roxithromycin and erythromycin in chlamydia-negative non-gonococcal urethritis.
    Worm AM
    Acta Derm Venereol; 1990; 70(3):269-71. PubMed ID: 1972850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections.
    Müller O
    J Antimicrob Chemother; 1996 Jun; 37 Suppl C():83-92. PubMed ID: 8818849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of roxithromycin against respiratory pathogens.
    Facinelli B; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():33-5. PubMed ID: 12041781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumonia.
    Poirier R
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():109-16. PubMed ID: 1827096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.